Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma

Oncogene

Volumn 31, Issue 21, 2012, Pages 2640-2652

  Chang, C Y ^a,b   Lin, S C ^b   Su, W H ^c   Ho, C M ^d,e   Jou, Y S ^a,b,e  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^e ACADEMIA SINICA   (Taiwan)

Author keywords

hepatocellular carcinoma; LIM domain; LMCD1; metastasis; somatic mutations

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ACTIN; ESTROGEN; RAC1 PROTEIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; LAMELLIPODIUM; LIM AND CYSTEINE RICH DOMAINS 1 GENE; LIVER CELL CARCINOMA; LUNG METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; SOMATIC MUTATION; STRESS FIBER; UPREGULATION;

ANIMALS; BETA-GLUCANS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CO-REPRESSOR PROTEINS; GENE AMPLIFICATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIM DOMAIN PROTEINS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; POINT MUTATION; PSEUDOPODIA; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; UP-REGULATION;

MURINAE;

EID: 84861494687     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.440     Document Type: Article

References (48)

1. Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y. (2005). LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res 65: 4587-4597. (Pubitemid 40740794)
2. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O et al. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393: 805-809. (Pubitemid 28299494)
3. Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R. (2006). LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer 118: 2703-2710. (Pubitemid 43673347)
4. Barrientos T, Frank D, Kuwahara K, Bezprozvannaya S, Pipes GC, Bassel-Duby R et al. (2007). Two novel members of the ABLIM protein family, ABLIM-2 and-3, associate with STARS and directly bind F-actin. J Biol Chem 282: 8393-8403. (Pubitemid 47093616)
5. Bespalova IN, Burmeister M. (2000). Identification of a novel LIM domain gene, LMCD1, and chromosomal localization in human and mouse. Genomics 63: 69-74. (Pubitemid 30112240)
6. Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. (1991). The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 88: 4367-4371. (Pubitemid 21914541)
7. Challen C, Guo K, Collier JD, Cavanagh D, Bassendine MF. (1992). Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas. J Hepatol 14: 342-346.
8. Chen CF, Hsu EC, Lin KT, Tu PH, Chang HW, Lin CH et al. (2010). Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma. Hepatology 52: 1690-1701.
9. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS et al. (2009). Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10: 25-34.
10. Coutts AS, MacKenzie E, Griffith E, Black DM. (2003). TES is a novel focal adhesion protein with a role in cell spreading. J Cell Sci 116: 897-906. (Pubitemid 36367639)
11. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O et al. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851. (Pubitemid 28350577)
12. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. (1995). M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11: 447-449.
13. Dudek P, Picard D. (2008). Genomics of signaling crosstalk of estrogen receptor alpha in breast cancer cells. PLoS One 3: e1859.
14. Farazi PA, DePinho RA. (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687. (Pubitemid 44286000)
15. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. (2004). Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 101: 7618-7623. (Pubitemid 38658078)
16. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG et al. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently downregulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099. (Pubitemid 47037488)
17. Griffith E, Coutts AS, Black DM. (2005). RNAi knockdown of the focal adhesion protein TES reveals its role in actin stress fibre organisation. Cell Motil Cytoskeleton 60: 140-152. (Pubitemid 40316154)
18. Grise F, Bidaud A, Moreau V. (2009). Rho GTPases in hepatocellular carcinoma. Biochim Biophys Acta 1795: 137-151.
19. Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A et al. (2007). Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 96: 296-305. (Pubitemid 46160635)
20. Harvell DM, Richer JK, Allred DC, Sartorius CA, Horwitz KB. (2006). Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture. Endocrinology 147: 700-713. (Pubitemid 43112986)
21. Imbeaud S, Ladeiro Y, Zucman-Rossi J. (2010). Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin Liver Dis 30: 75-86.
22. Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY et al. (2008). Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res 68: 132-142. (Pubitemid 351380114)
23. Jou YS, Lee CS, Chang YH, Hsiao CF, Chen CF, Chao CC et al. (2004). Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. Cancer Res 64: 3030-3036.
24. Kadrmas JL, Beckerle MC. (2004). The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5: 920-931. (Pubitemid 39486543)
25. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M et al. (1987). Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 60: 810-819.
26. Kang S, Xu H, Duan X, Liu JJ, He Z, Yu F et al. (2000). PCD1, a novel gene containing PDZ and LIM domains, is overexpressed in several human cancers. Cancer Res 60: 5296-5302.
27. Khurana T, Khurana B, Noegel AA. (2002). LIM proteins: association with the actin cytoskeleton. Protoplasma 219: 1-12. (Pubitemid 34166167)
28. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S et al. (1999). DNA copy number losses in human neoplasms. Am J Pathol 155: 683-694. (Pubitemid 29426813)
29. Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K. (1999). Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29: 1858-1862. (Pubitemid 29247061)
30. Liu CY, Chao TK, Su PH, Lee HY, Shih YL, Su HY et al. (2009). Characterization of LMX-1A as a metastasis suppressor in cervical cancer. J Pathol 219: 222-231.
31. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al. (2008). Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390.
32. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. (1999). p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116: 394-400. (Pubitemid 29055363)
33. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. (Pubitemid 47187346)
34. Mueller W, Nutt CL, Ehrich M, Riemenschneider MJ, von Deimling A, van den Boom D et al. (2007). Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 26: 583-593. (Pubitemid 46160971)
35. Murata H, Tsuji S, Tsujii M, Sakaguchi Y, Fu HY, Kawano S et al. (2004). Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells. Lab Invest 84: 1050-1059. (Pubitemid 39025039)
36. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP et al. (2001). Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 85: 697-704. (Pubitemid 32929468)
37. Ozturk M. (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338: 1356-1359.
38. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
39. Pratt SJ, Epple H, Ward M, Feng Y, Braga VM, Longmore GD. (2005). The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J Cell Biol 168: 813-824. (Pubitemid 40328164)
40. Rath N, Wang Z, Lu MM, Morrisey EE. (2005). LMCD1/dyxin is a novel transcriptional cofactor that restricts GATA6 function by inhibiting DNA binding. Mol Cell Biol 25: 8864-8873. (Pubitemid 41429078)
41. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250. (Pubitemid 30132191)
42. Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM. (2001). The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 20: 2844-2853. (Pubitemid 32549841)
43. Visvader JE, Venter D, Hahm K, Santamaria M, Sum EY, O'Reilly L et al. (2001). The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc Natl Acad Sci USA 98: 14452-14457. (Pubitemid 33121412)
44. Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W et al. (2001). Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 31: 221-227. (Pubitemid 32521752)
45. Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M. (1999). Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18: 4879-4883. (Pubitemid 29423571)
46. Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H et al. (1999). PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 18: 3181-3185. (Pubitemid 29261240)
47. Yoshida T, Kobayashi T, Itoda M, Muto T, Miyaguchi K, Mogushi K et al. (2010). Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data. Cancer Inform 9: 147-161.
48. Zheng Q, Zhao Y. (2007). The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction. Biol Cell 99: 489-502. (Pubitemid 47365607)